Thrombocytopenia and sideroblastic anemia with pyrazinoic acid amide (pyrazinamide) therapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000009:adverse effects; D000756:Anemia, Sideroblastic / Q000139:chemically induced*; D000995:Antitubercular Agents / Q000009:adverse effects*; D003523:Cycloserine / Q000009:adverse effects; D005260:Female; D006801:Humans; D007501:Iron / Q000097:blood; D007538:Isoniazid / Q000009:adverse effects; D008875:Middle Aged; D011485:Protein Binding; D011718:Pyrazinamide / Q000009:adverse effects; D013307:Streptomycin / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D011718:Pyrazinamide; D003523:Cycloserine; D007501:Iron; D007538:Isoniazid; D013307:Streptomycin